IP Library Granted Patent US 8,921,583
Granted Patent B2
US 8,921,583 · App. 13/757,113 · Granted Dec 30, 2014

Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxides

Inventors: Pasit Phiasivongsa (Brentwood, CA); Louis C. Sehl (Redwood City, CA); William Dean Fuller (San Diego, CA); Guy J. Laidig (Menlo Park, CA)
Assignee: Onyx Therapeutics, Inc.
C07K5/1016C07D301/03C07K1/1075C07K1/306C07C51/412C07K5/1008C07D303/36C07C53/18A61K38/00C07D301/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,921,583
App. No.
13/757,113
Granted
Dec 30, 2014
Kind
B2
Abstract

The invention relates to crystalline peptide keto epoxide compounds, methods of their preparation, and related pharmaceutical compositions. This invention also relates to methods for the preparation of amino acid keto-epoxides. Specifically, allylic ketones are stereoselectively converted to the desired keto epoxides.

Claims (19)

1. A method for the preparation of a crystalline compound of Formula (III),

wherein X is trifluorocetate, comprising (i) preparing a solution of a compound of Formula (IV) in an organic solvent, wherein PG is a suitable protecting group

(ii) adding trifluoroacetic acid; (iii) bringing the solution to supersaturation to cause formation of crystals; and (iv) isolating the crystals, wherein said crystalline compound has 2θ values of 8.84; 15.18; 15.32;16.20; 16.82; 17.66; 18.26; 19.10; 21.20; 22.58; 23.06; 23.52; 25.32; 26.58; 28.60; 30.08; 30.48; 30.84; 32.20; 36.14; and 37.12.

2. A method of claim 1 , wherein PG is selected from Boc and Cbz and X is trifluoroacetate.

3. A method of claim 1 , wherein the organic solvent is selected from dichloromethane, ethyl acetate, isopropyl acetate, isobutyl acetate, butyl acetate, propyl acetate, diethyl ether, methyl tert-butyl ether (MTBE), or any combination thereof.

4. A method of claim 3 , wherein the organic solvent is selected from dichloromethane, ethyl acetate, MTBE, or any combination thereof.

5. A method of claim 1 , wherein bringing the solution to supersaturation comprises addition of an anti-solvent, allowing the solution to cool, reducing the volume of the solution, or any combination thereof.

6. A method of claim 5 , wherein bringing the solution to supersaturation comprises adding an anti-solvent, cooling the solution to ambient temperature or lower, and reducing the volume of the solution.

7. A method of claim 5 , wherein the anti-solvent is hexanes or heptanes.

8. A method of claim 1 , further comprising washing the crystals.

9. A method of claim 8 , wherein the washing comprises washing with a liquid selected from anti-solvent, dichloromethane, ethyl acetate, isopropyl acetate, isobutyl acetate, butyl acetate, propyl acetate, diethyl ether, and methyl tert-butyl ether, or any combination thereof.

10. A method of claim 9 , wherein washing comprises washing with anti-solvent.

11. A method of claim 10 , wherein the anti-solvent is hexanes or heptanes.

12. A method of claim 1 , wherein isolating the crystals comprises filtering the crystals.

13. A method of claim 1 , further comprising drying the crystals under reduced pressure.

14. A crystalline compound having a structure of Formula (III)

wherein X is trifluoroacetate, and wherein said crystalline compound has 2θ values of 8.84; 15.18; 15.32;16.20; 16.82; 17.66; 18.26; 19.10; 21.20; 22.58; 23.06; 23.52; 25.32; 26.58; 28.60; 30.08; 30.48; 30.84; 32.20; 36.14; and 37.12.

15. A crystalline compound of claim 14 , having a DSC thermogram substantially as shown in FIG. 9 .

16. A crystalline compound of claim 14 , having an XRPD pattern substantially as shown in FIG. 10 .

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 6, 2013
From: PHIASIVONGSA, PASIT; SEHL, LOUIS C.; FULLER, WILLIAM DEAN; LAIDIG, GUY J.
To: PROTEOLIX, INC.
Reel/Frame 029763/0853 →
MERGER Recorded Feb 6, 2013
From: PROTEOLIX, INC.
To: ONYX THERAPEUTICS, INC.
Reel/Frame 029763/0920 →
Continuity (4)
Division 12287043 · Oct 3, 2008
Provisional Application 60997613 · Oct 4, 2007
Provisional Application 61008987 · Dec 20, 2007
Related Publication 20130150289A1 · Jun 13, 2013